|
Genechem
shrna construction and stable clone selection Shrna Construction And Stable Clone Selection, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/shrna construction and stable clone selection/product/Genechem Average 90 stars, based on 1 article reviews
shrna construction and stable clone selection - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Genechem
lentiviral shrna clones targeting human lsh and the non-targeting control construct Lentiviral Shrna Clones Targeting Human Lsh And The Non Targeting Control Construct, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lentiviral shrna clones targeting human lsh and the non-targeting control construct/product/Genechem Average 90 stars, based on 1 article reviews
lentiviral shrna clones targeting human lsh and the non-targeting control construct - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Shanghai GenePharma
lentiviruses-shrna for stable knockdown of pygb or the negative control construct Lentiviruses Shrna For Stable Knockdown Of Pygb Or The Negative Control Construct, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lentiviruses-shrna for stable knockdown of pygb or the negative control construct/product/Shanghai GenePharma Average 90 stars, based on 1 article reviews
lentiviruses-shrna for stable knockdown of pygb or the negative control construct - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Transomic Technologies Inc
non-targeting shrna control clone id: tlnsu4420 Non Targeting Shrna Control Clone Id: Tlnsu4420, supplied by Transomic Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/non-targeting shrna control clone id: tlnsu4420/product/Transomic Technologies Inc Average 90 stars, based on 1 article reviews
non-targeting shrna control clone id: tlnsu4420 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cleave Biosciences
a549 cells stably expressing inducible control shrna or inducible shrna targeting vcp/p97 (clones 4252–2 and 4252–3) ![]() A549 Cells Stably Expressing Inducible Control Shrna Or Inducible Shrna Targeting Vcp/P97 (Clones 4252–2 And 4252–3), supplied by Cleave Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/a549 cells stably expressing inducible control shrna or inducible shrna targeting vcp/p97 (clones 4252–2 and 4252–3)/product/Cleave Biosciences Average 90 stars, based on 1 article reviews
a549 cells stably expressing inducible control shrna or inducible shrna targeting vcp/p97 (clones 4252–2 and 4252–3) - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Oncogene
Article Title: The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
doi: 10.1038/s41388-018-0651-z
Figure Lengend Snippet: VCP/p97-governed proteostasis is tied to metabolic pathways and nutrient availability. a Network graph of leading-edge enriched genes from the top three most highly enriched KEGG pathways. Edge weight and size indicate strength of correlation between genes/nodes. Nodes are coloured by the pathways each gene contributes to. b GSEA plots of the KEGG term Metabolic Pathways, with genes ranked by correlation with VCP/p97 expression, in the Cancer Cell Line Encyclopedia (CCLE) and in patient-derived tumour cells in the Myeloma IX study. The correlation value of individual genes is indicated by black bars (left axis) and running enrichment score is highlighted by red line (right axis). NES normalised enrichment score. c Relative mRNA levels of the indicated genes in A549 cells stably expressing non-targeting control (NTC) or one of two IPTG-inducible VCP/p97 shRNAs after 48 h of IPTG treatment in complete medium (25 mM glucose, 2 mM glutamine), followed by 24 h maintenance in complete, low glucose (1 mM glucose, 2 mM glutamine) or no glutamine (25 mM glucose, 0 mM glutamine) medium supplemented with 500 μM IPTG. Data shown are mean and SEM, n = 3 (two-way ANOVA with Tukey’s multiple comparisons test). d Relative mRNA levels of the indicated genes in A549 cells grown under different conditions of nutrient availability and treated with CB5083 (1 μM) as indicated for 16 h. Data shown are mean and SEM, n = 3 (two-way ANOVA with Tukey’s multiple comparisons test). e Proportion of non-viable A549 cells as determined by Annexin V and 7-AAD staining after treatment with CB5083 under the indicated conditions of nutrient availability for 48 h. Data shown are mean and SEM, n = 3 (two-way ANOVA with Sidak’s multiple comparisons test). f VCP/p97 mRNA expression in the indicated cell lines grown in complete, low glucose or no glutamine medium for 16 h (A549), 24 h (DU145), or 48 h (A172). Data shown are mean and SEM, n = 3 (Mann–Whitney test)
Article Snippet:
Techniques: Expressing, Derivative Assay, Stable Transfection, Control, Staining, MANN-WHITNEY
Journal: Oncogene
Article Title: The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
doi: 10.1038/s41388-018-0651-z
Figure Lengend Snippet: Metabolite responses to VCP/p97 inhibition. A549 cells were grown in complete (25 mM glucose, 2 mM glutamine), low glucose (1 mM glucose, 2 mM glutamine), or no glutamine (25 mM glucose, 0 mM glutamine) medium for 16 h followed by intracellular metabolite extraction and gas chromatography-mass spectrometry. Data show the effects of CB5083 treatment (1 μM) for 16 h. a Volcano plots indicating metabolites with significant changes (coloured). The horizontal dashed line represents a multiple testing-adjusted p -value of 0.05, and the vertical dashed lines represent log 2 fold changes of 0.67 and 1.5, respectively. b Bar graphs show the effect of treatment with CB5083 on individual metabolites (fold change of treatment to control for each of the three media compositions). Comparisons with significant effects (two-way ANOVA, n = 4 per experimental condition) are outlined in red
Article Snippet:
Techniques: Inhibition, Extraction, Gas Chromatography, Mass Spectrometry, Control
Journal: Oncogene
Article Title: The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
doi: 10.1038/s41388-018-0651-z
Figure Lengend Snippet: GCN2 modulates proteotoxic stress and ERK signalling in response to VCP/p97 inhibition. a Immunoblot for GCN2 and β-tubulin on extracts from untransduced A549 cells and A549 cells stably expressing targeting (shGCN2) or non-targeting (shNTC) shRNA . b-e A549 cells stably expressing non-targeting control (shNTC) or one of two shRNAs targeting GCN2 (shGCN2) were grown in complete (25 mM glucose, 2 mM l -glutamine), low glucose (1 mM glucose, 2 mM glutamine), or no glutamine (25 mM glucose, 0 mM glutamine) medium. CB5083 was used at 1 μM. b Proportion of non-viable A549 cells as determined by Annexin V-FITC and 7-AAD staining after 48 h of experimental treatment. Data shown are mean and SEM, n = 3 (two-way ANOVA with Tukey’s multiple comparisons test). c mRNA levels relative to shNTC expressing cells grown in complete medium after 16 h of experimental treatment. Data shown are mean and SEM, n = 3 (two-way ANOVA with Tukey’s multiple comparisons test). d Immunoblot analyses on whole-cell extracts from A549 cells (three independent experiments) stably expressing shNTC or shGCN2(1). Bar graphs show relative phosphorylated ERK1/2 immunoblot band intensities (mean and SEM) compared to control cells. e Proportion of non-viable A549 cells as determined by Annexin V and 7-AAD staining after 24 h of experimental treatment with AZD6244, U0126, and CB5083 for 24 h. Mean and SEM of n = 3 experiments is shown (two-way ANOVA and Tukey’s multiple comparisons for effects of AZD6244 and U0126 compared to vehicle-treated or CB5083-treated cells; two-way ANOVA and Bonferroni’s multiple comparisons test for effects of shGCN2 compared to shNTC under the same experimental conditions (grey asterisks); exact p values for all comparisons are shown in Supplementary Figure )
Article Snippet:
Techniques: Inhibition, Western Blot, Stable Transfection, Expressing, shRNA, Control, Staining
Journal: Oncogene
Article Title: The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
doi: 10.1038/s41388-018-0651-z
Figure Lengend Snippet: GCN2 attenuates autophagy in response to metabolic and proteotoxic stress. A549 cells stably expressing non-targeting control (shNTC) or one of two shRNAs targeting GCN2 (shGCN2) were grown in complete (25 mM glucose, 2 mM l -glutamine), low glucose (1 mM glucose, 2 mM glutamine), or no glutamine (25 mM glucose, 0 mM glutamine) medium. CB5083 was used at 1 μM. a GSEA plot of KEGG autophagy pathway with genes ranked by correlation with VCP/p97 expression. The correlation value of individual genes is indicated by black bars (left axis) and running enrichment score is highlighted by red line (right axis). NES normalised enrichment score. b mRNA levels relative to shNTC expressing cells grown in complete medium after 16 h of experimental treatment. Data shown are mean and SEM, n = 3 (two-way ANOVA with Tukey’s multiple comparisons test). c Immunoblot analyses on whole-cell extracts from A549 cells (three independent experiments) stably expressing shNTC or shGCN2(1). Bar graphs show relative LC3BII and p62 immunoblot band intensities, compared to control cells (mean and SEM). d Immunoblot analyses on whole-cell extracts from A549 cells treated with CB5083 (1 μM) for 24 h and bafilomycin A1 (100 nM) for 16 h. e Propoof non-viable A549 cells treated with CB5083 (1 μM) for 48 h and bafilomycin A1 (100 nM) for 40 h. Data shown are mean and SEM, n = 3 (two-way ANOVA and Tukey’s multiple comparisons test)
Article Snippet:
Techniques: Stable Transfection, Expressing, Control, Western Blot
Journal: Oncogene
Article Title: The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
doi: 10.1038/s41388-018-0651-z
Figure Lengend Snippet: Effects of GCN2 on metabolites and protein synthesis. a Bar graphs show metabolite levels in shGCN2 A549 cells compared to shNTC cells in different media (fold change for each of the three media compositions (16 h), and metabolite levels in shGCN2(1) cells (fold change to shNTC cells) after treatment with CB5083 (1 μM, 16 h). Comparisons with significant effects are outlined in red ( n = 4, two-way ANOVA). b , c Immunoblot analyses for the indicated proteins on whole-cell extracts from A549 cells (three independent experiments) stably expressing shNTC or shGCN2(1). Bar graphs show relative immunoblot band intensities, compared to control cells (mean and SEM)
Article Snippet:
Techniques: Western Blot, Stable Transfection, Expressing, Control